loader
Please Wait
Applying Filters...
menu
    • menu

    Product Under Development 2025 services provided by Synnat Pharma

    Virtual BoothMenuSynnat Pharma
    Product Under Development 2025

    PDF Upload May, 2025
    News
    FDA Eliminates Risk Evaluation, Mitigation for Car-T Therapies

    28 Jun 2025

    // REUTERS

    Gilead Shares Rise After Top Court Ruling on Preventive Coverage

    28 Jun 2025

    // REUTERS

    US Senator Probes GSK's Halt of Children's Asthma Inhaler

    28 Jun 2025

    // REUTERS

    DATA COMPILATION
    #PharmaFlow

    Synnat VB RM

    Contact Supplier

    Website

    Pharmaconex

    Exhibiting

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025
    Xls

    CATEGORY PAGE
    Menu

    Synnat Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PI70279